Inventor · disambiguated record
Cecilia M. Bastos
Also filed as: BASTOS CECILIA · BASTOS CECILIA M
34 granted patents·11 pending applications·234 citations·filing 1994–2024
97Inventor score
Top patents by PatentIndex Score
45 records- 0197US9745292B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 29, 2017·14 cites·26 claims
- 0296US10017503B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·11 cites·28 claims
- 0396US9790219B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·16 cites·38 claims
- 0494US10548878B2Compounds, compositions, and methods of increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Feb 4, 2020·8 cites·23 claims
- 0593US10550106B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Feb 4, 2020·9 cites·13 claims
- 0691US9850262B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·6 cites·25 claims
- 0790US11242361B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·2 cites·34 claims
- 0890US10174014B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jan 8, 2019·9 cites·25 claims
- 0990US8304447B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2008·Granted Nov 6, 2012·18 cites·20 claims
- 1088US8309593B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2009·Granted Nov 13, 2012·15 cites·15 claims
- 1188US7119120B2Phosphate transport inhibitorsGENZYME CORP·Filed 2002·Granted Oct 10, 2006·34 cites·10 claims
- 1288US2024109922A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1387US10662207B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted May 26, 2020·4 cites·27 claims
- 1487US10392378B2Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·7 cites·8 claims
- 1587US10392372B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·6 cites·11 claims
- 1687US8940776B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Jan 27, 2015·11 cites·19 claims
- 1787US2024368198A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1886US10344023B2Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jul 9, 2019·6 cites·20 claims
- 1983US7109184B2Phosphate transport inhibitorsGENZYME CORP·Filed 2003·Granted Sep 19, 2006·15 cites·28 claims
- 2082US9272996B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsSIEGEL CRAIG·Filed 2012·Granted Mar 1, 2016·6 cites·16 claims
- 2180US2024139158A1Methods of treating pulmonary diseases and disordersPROTEOSTASIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2279US10738040B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·1 cites·23 claims
- 2379US9745294B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Aug 29, 2017·3 cites·24 claims
- 2476US11958873B2Proteasome activity enhancing compoundsKINETA INC·Filed 2021·Granted Apr 16, 2024·0 cites·35 claims
- 2576US11136313B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Oct 5, 2021·1 cites·24 claims
- 2676US10738011B2Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 11, 2020·1 cites·4 claims
- 2775US10899751B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jan 26, 2021·1 cites·17 claims
- 2875US5708022AMethod for inhibiting immune responsePROCEPT INC·Filed 1995·Granted Jan 13, 1998·20 cites·28 claims
- 2973US12319698B2Proteasome activity enhancing compoundsKINETA INC·Filed 2022·Granted Jun 3, 2025·0 cites·22 claims
- 3072US11248010B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 15, 2022·0 cites·11 claims
- 3172US9744153B22-acylaminopropoanol-type glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2016·Granted Aug 29, 2017·1 cites·14 claims
- 3269US11098035B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 3369US2022175735A1Methods of treating pulmonary diseases and disordersPROTEOSTASIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3467US2022227739A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3564US2018282352A1Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3663US11560385B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·0 cites·21 claims
- 3761US11083709B2Compounds, compositions, and methods of increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·0 cites·11 claims
- 3861US2018369209A1Methods of treating pulmonary diseases and disordersPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3958US7754200B2Phosphate transport inhibitorsGENZYME CORP·Filed 2006·Granted Jul 13, 2010·0 cites·19 claims
- 4057US2018093981A12-Acylaminopropoanol-Type Glucosylceramide Synthase InhibitorsGENZYME CORP·Filed 2017·Application pending·0 cites
- 4154US2018147187A1Compounds, compositions, and methods for increasing cftr activityPROTEOSTASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4250US2007021509A1Phosphate transport inhibitorsJOZEFIAK THOMAS H·Filed 2006·Application pending·0 cites
- 4350US2021369749A1Compounds, compositions, and methods for increasing cftr activityPROTEOSTASIS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4444US8703811B2Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenaseBASTOS CECILIA·Filed 2009·Granted Apr 22, 2014·0 cites·11 claims
- 4544US5512687ACompounds for inhibiting immune responsePROCEPT INC·Filed 1994·Granted Apr 30, 1996·9 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Cecilia M. Bastos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →